IRIDEX Corp Reports Annual Meeting Results, Discloses Proxy‑Vote Investigation

What Happened

• IRIDEX Corporation reconvened its 2026 Annual Meeting on July 10, 2026 (initially convened and adjourned on June 12, 2026) after an internal investigation into unusually divergent director vote tallies. As of the April 17, 2026 record date, 17,395,350 common shares and 600,000 Series B Preferred shares were outstanding. Holders of 13,831,856 common shares (79.51%) and all 600,000 Series B Preferred shares attended in person or by proxy, constituting a quorum.
• All five director nominees were elected under IRIDEX’s plurality voting standard despite large “withheld” votes for two independent directors. The Board concluded a majority believes the voting pattern reflects a “stealth proxy campaign” involving at least one director and possibly Novel Inspiration, and that the conduct likely implicated fiduciary duties, SEC proxy rules, and Schedule 13D reporting requirements.

Key Details

• Director vote highlights (includes Series B Preferred votes, which carry 5 votes each): Nick Chen — 12,523,088 for / 652,399 withheld; Beverly A. Huss — 5,739,133 for / 7,436,354 withheld; Scott Shuda — 5,656,948 for / 7,518,539 withheld. All five nominees were elected.
• Ratification of auditor: BPM LLP was ratified as independent registered public accounting firm — 16,675,096 for, 62,657 against, 94,103 abstain.
• Advisory (non-binding) say-on-pay: 12,222,760 for, 593,811 against, 358,916 abstain (plus broker non-votes).
• Novel Inspiration amended a Schedule 13D on July 13, 2026 disclosing affiliates hold 6,738,238 shares (about 39% of outstanding common shares and ~29.9% of fully diluted shares). The Company says Novel failed to timely file required Form 4/Schedule 13D disclosures and reported open‑market purchases from March 25, 2025 to March 30, 2026.
• The Board is continuing its investigation, including whether Novel or its group traded around the sharp March 27, 2026 market drop and whether purchases occurred during insider “closed windows.”

Why It Matters

• For investors: the filing signals potential governance and disclosure risks. A large strategic investor (Novel) and an affiliated director are implicated in coordinated voting and belated disclosure of a substantial stake, which could lead to regulatory scrutiny or legal action and could affect investor confidence.
• The immediate corporate governance outcome was that all directors remained in place (plurality voting), but the Company is actively investigating and engaging stockholders; further developments (regulatory filings, litigation, board actions) could materially affect the company’s leadership and share ownership structure.